Wall Street

Crossmark Global Investments chief investment officer Bob Doll says that corporations in the third quarter were 'very successful in passing their cost pressures on to price increases and, therefore, retaining profit margins having great earnings.'

Rosecliff Capital CEO Mike Murphy and Gett CEO Dave Waiser discuss the merger and the company's long-term goals.

CFRA chief investment strategist Sam Stovall argues consumer prices will peak in January 2022.

'Making Money' host helps investors take back their financial future in 'New Investor Revolution' special.

BMO Capital Markets Chief Investment Strategist Brian Belski on what's driving growth in the markets.

Villere & Co. portfolio manager Sandy Villere says he is avoiding 'overpriced' technology stocks given the thinking that eventually Federal Reserve will raise rates and advises people not to be around 'when the music stops on that sector.' 

St. Louis Fed President James Bullard argues that if data reveals 'inflation is more persistent than what we are seeing right now,' then 'sooner action' may be needed 'in order to keep inflation under control.' 

St. Louis Fed President James Bullard notes that the level of GDP is 'above pre-pandemic levels so we already fully recovered in that sense from the pandemic and the pandemic isn't even over yet.' 

Ken Leon, Center for Financial Research and Analysis research director, argues large-cap high quality growth stocks are driving markets. 

House Minority Whip Rep. Steve Scalise reacts to spending package push back and says Americans don't want 'radical' policy.

Oppenheimer managing director Jason Helfstein joins Commerce Street Capital CEO Dory Wiley on 'The Claman Countdown'

Wealth Consulting Group CEO reacts to the Fed's dovish view on inflation on 'Mornings with Maria'

Payne Capital Management president and UBS advisor Alli McCartney discuss inflation and the labor market on 'Mornings with Maria'

BMO Capital Markets chief investment strategist Brian Belski and RealInvestmentAdvice.com CIO Lance Roberts evaluate the bull market on 'Making Money.'

NatWest Markets co-head of global economics Michelle Girard, Mayflower Advisors managing partner Larry Glazer and MoffettNathanson partner Lisa Ellis discuss how COVID, the latest jobs report and the Federal Reserve’s actions impact the markets. 

Pfizer CEO Albert Bourla says studies showed the COVID experimental antiviral pill 'worked extremely well' even if it wasn't taken as soon as people experienced symptoms. 

Pfizer CEO Albert Bourla discusses the company's experimental antiviral pill for COVID-19, which researchers found cut rates of hospitalization and death by nearly 90% in high-risk adults. 

Blue Line Capital President Bill Baruch provides insight into inflation, the Fed, yields and today’s markets. 

Evercore ISI senior managing director Mark Mahaney weighs in on today’s markets and shares his investing tips. 

'Making Money' host explains his strategy to investing in high short interest stocks.